Predicting the risk of sporadic elevated bilirubin levels and diagnosing Gilbert’s syndrome by genotyping UGT1A1*28 promoter polymorphism
S.K. Rauchschwalbe1, M.T. Zühlsdorf2, U. Schühly2, J. Kuhlmann2
1 Institute of Pharmacology and Toxicology, Julius Maximilian University Würzburg, and 2 Pharmaceutical Research Center, Institute of Clinical Pharmacology, Bayer AG, Wuppertal, Germany
| Shopping Overview | ||||
| Type | Qtty | Discount | VAT | Price |
| Your basket is empty | ||||
| View Cart | ||||